Kyverna Therapeutics Inc. – Transcripts

NASDAQ: KYTX
Share price (9/22/26): $7.51
Market cap (9/22/26): $464 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Other Revised 09/14/26 Kyverna Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 04:05 PM 09/14/26

Other Revised 03/13/26 Kyverna Therapeutics, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 11:20 AM 03/09/26

Other Revised 01/21/26 Kyverna Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:45 AM 01/14/26

CY 2025

Other Revised 12/17/25 Kyverna Therapeutics, Inc. - Special Call 12/15/25

Other Revised 04/14/25 Kyverna Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 05:15 PM 01/13/25